Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand–Ongoing barriers and enablers

K Gatman, R May, C Crowther - Australian and New Zealand …, 2020 - Wiley Online Library
Background Clinical practice guidelines recommend the use of antenatal magnesium
sulphate for fetal neuroprotection before preterm birth at< 30 weeks' gestation. Aims This …
被引用次数：9 相关文章

Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand–Ongoing barriers and enablers.

K Gatman, R May, C Crowther - Australian & New Zealand …, 2020 - search.ebscohost.com
Background: Clinical practice guidelines recommend the use of antenatal magnesium
sulphate for fetal neuroprotection before preterm birth at &lt; 30 weeks' gestation. Aims: This …

Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand-Ongoing barriers and enablers

K Gatman, R May, C Crowther - The Australian & New …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Clinical practice guidelines recommend the use of antenatal magnesium
sulphate for fetal neuroprotection before preterm birth at< 30 weeks' gestation. Aims This …

Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand-Ongoing barriers and enablers.

K Gatman, R May, C Crowther - The Australian & New Zealand …, 2019 - europepmc.org
Background Clinical practice guidelines recommend the use of antenatal magnesium
sulphate for fetal neuroprotection before preterm birth at< 30 weeks' gestation. Aims This …